Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
In this 42-minute educational video, Dr. Shonali Midha from Dana-Farber Cancer Institute explores the applications of CAR T-cell therapy and bispecific antibody therapy for patients with relapsed/refractory multiple myeloma. Discover the latest developments in immune-based treatment approaches for multiple myeloma, including clinical outcomes, patient selection criteria, and emerging therapeutic strategies. Gain valuable insights into how these innovative immunotherapies are transforming the treatment landscape for patients with this challenging hematologic malignancy.
